Account wins from 03/17/06 News Brief

Share this article:
Mc|K Healthcare has been retained by Critical Therapeutics of Lexington, MA, for the professional marketing and promotion of Zyflo (zileuton tablets). Zyflo was approved by the FDA in Sept. 2005 for the prevention and chronic treatment of asthma in adults and children 12 years of age and older.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.